JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SDT
5476
DELISTED
SANDRIDGE MISSISSIPPIAN TRUST I
SDT
| $3K | ﹤0.01% |
4,000
| – | – |
2019 Q1
1 quarter
|
|
|
PES
5477
DELISTED
Pioneer Energy Services Corp.
PES
| $3K | ﹤0.01% |
12,525
-64,930
| -84% | -$71K |
2013 Q2
24 quarters
|
|
|
FM
5478
DELISTED
iShares Frontier and Select EM ETF
FM
| $3K | ﹤0.01% |
114
-719
| -86% | -$20.7K |
2018 Q4
2 quarters
|
|
5479
Achieve Life Sciences
ACHV
$746M
| $2K | ﹤0.01% |
+60
| New | +$4.24K |
2019 Q2
0 quarters
|
|
|
BTO
5480
John Hancock Financial Opportunities Fund
BTO
$714M
| $2K | ﹤0.01% |
+50
| New | +$1.63K |
2019 Q2
0 quarters
|
|
5481
CB Financial Services
CBFV
$187M
| $2K | ﹤0.01% |
103
-1,037
| -91% | -$24.4K |
2018 Q2
4 quarters
|
|
5482
Cardiff Oncology
CRDF
$87.1M
| $2K | ﹤0.01% |
846
| – | – |
2017 Q3
7 quarters
|
|
5483
ProShares UltraShort Dow 30
DXD
$43.3M
| $2K | ﹤0.01% |
12
-58
| -83% | -$8.09K |
2018 Q4
2 quarters
|
|
5484
Gevo
GEVO
$324M
| $2K | ﹤0.01% |
1,200
-10
| -0.8% | -$21 |
2018 Q1
5 quarters
|
|
|
GRX
5485
Gabelli Healthcare & Wellness Trust
GRX
$136M
| $2K | ﹤0.01% |
225
| – | – |
2015 Q4
14 quarters
|
|
5486
Horizon Technology Finance
HRZN
$310M
| $2K | ﹤0.01% |
+200
| New | +$2.36K |
2019 Q2
0 quarters
|
|
5487
Kodak
KODK
$960M
| $2K | ﹤0.01% |
850
-3,278
| -79% | -$8.13K |
2017 Q4
6 quarters
|
|
|
KG
5488
Kestrel Group
KG
$41M
| $2K | ﹤0.01% |
153
-3,824
| -96% | -$52.8K |
2013 Q2
24 quarters
|
|
5489
United-Guardian
UG
$32.8M
| $2K | ﹤0.01% |
+100
| New | +$1.93K |
2019 Q2
0 quarters
|
|
5490
USA Compression Partners
USAC
$3.68B
| $2K | ﹤0.01% |
96
| – | – |
2015 Q4
14 quarters
|
|
5491
ProShares VIX Mid-Term Futures ETF
VIXM
$49.9M
| $2K | ﹤0.01% |
100
-800
| -89% | -$17.4K |
2018 Q4
2 quarters
|
|
5492
Invesco Municipal Trust
VKQ
$476M
| $2K | ﹤0.01% |
197
-144,132
| -100% | -$1.75M |
2019 Q1
1 quarter
|
|
|
PHLT
5493
DELISTED
Performant Healthcare Inc
PHLT
| $2K | ﹤0.01% |
2,000
| – | – |
2018 Q4
2 quarters
|
|
|
VIVS
5494
VivoSim Labs
VIVS
$2.63M
| $2K | ﹤0.01% |
27
-98
| -78% | -$18.5K |
2015 Q4
14 quarters
|
|
|
VST.WS.A
5495
DELISTED
Vistra Corp.Warrants to purchase Common Stock (Expiring February 2, 2024)
VST.WS.A
| – | – |
0
| – | – |
2018 Q2
4 quarters
|
|
|
WINS
5496
DELISTED
Wins Finance Holdings Inc. Ordinary Shares (Cayman Islands)
WINS
| $2K | ﹤0.01% |
133
| – | – |
2016 Q4
10 quarters
|
|
|
SSI
5497
DELISTED
Stage Stores Inc
SSI
| $2K | ﹤0.01% |
2,037
| – | – |
2018 Q4
2 quarters
|
|
|
AREX
5498
DELISTED
Approach Resources Inc.
AREX
| $2K | ﹤0.01% |
8,037
-2,953
| -27% | -$915 |
2017 Q4
6 quarters
|
|
|
SPI
5499
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
| $2K | ﹤0.01% |
+1,026
| New | +$3.37K |
2019 Q2
0 quarters
|
|
5500
Aptevo Therapeutics
APVO
$3.19M
| – | – |
0
| – | – |
2017 Q2
8 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.